Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2969 of 5804
-
Can removing certain immune cells make stem cell transplants safer for myeloma patients?
Disease control CompletedThe purpose of this study is to test whether regulatory T-cell reduction is possible and safe in myeloma subjects undergoing autologous stem cell transplantation (ASCT).
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New study explores BRCA mutations in hispanic breast cancer patients
Knowledge-focused CompletedBackground: \- BRCA1 and BRCA2 gene mutations have been linked to a higher risk of developing breast cancer and other cancers, and may be associated with types of breast cancer that are more difficult to treat and more likely to recur. New cancer treatments are being developed s…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Personalized vitamin d dosing may beat standard approach in breast cancer patients
Disease control CompletedThe purpose of this study is to compare normalization of vitamin D serum level after 6 months of vitamin D supplementation adjusted to baseline vitamin D serum level vs.conventional vitamin D supplementation.
Phase: PHASE3 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Light-Activated therapy shows promise for tumor control without surgery
Knowledge-focused OngoingFrom 1996-present, we have used photodynamic therapy (PDT) to treat a number of neoplastic diseases both on prospective research protocols (for head and neck cancer, pleural malignancies, peritoneal carcinomatosis or sarcomatosis and prostate cancer) as well as for FDA approved a…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Can cutting four foods ease Kids' esophagus inflammation?
Disease control OngoingThis study is to observe the efficacy of the four food elimination diet.
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can a drug plus brain exercises boost recovery after stroke?
Symptom relief CompletedThe investigators would like to conduct a double blind placebo-controlled prospective study to show the impact of a treatment combining a specific cognitive rehabilitation program and acetylcholinesterase inhibitors on executive function of young patients 3 months after a first s…
Phase: PHASE2 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Robot vs. surgeon: which surgery is safer for pelvic organ prolapse?
Disease control CompletedThe primary objective of this study is to compare 30-day complication rates associated with promontofixation for pelvic organ prolapse performed via a robot-assisted laparoscopic technique versus a non-robot-assisted laparoscopic technique. Secondary objectives include comparing …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug combo targets tumors in patients with organ failure
Disease control OngoingThis phase I trial studies the side effects and the best dose of veliparib when given together with paclitaxel and carboplatin in treating patients with solid tumors that are metastatic or cannot be removed by surgery and liver or kidney dysfunction. Veliparib may stop the growth…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain training shows promise for bipolar thinking problems
Symptom relief CompletedThe purpose of the present study is to evaluate a neuroplasticity-oriented, computer-based cognitive remediation treatment program in patients with bipolar disorder and its effects on cognitive deficits and community functioning compared to an active, computer-based control.
Phase: NA • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Urine test may replace needle biopsy for kidney transplant patients
Knowledge-focused CompletedThe investigators have shown that epithelial-to-mesenchymal transition (EMT) markers in early protocol biopsies of the renal allograft predicts the progression of fibrosis during the first year post-transplantation. The investigators will develop a non-invasive approach for pred…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Drug combo aims to starve and block cancer in early trial
Disease control OngoingThis phase I trial studies the side effects and best dose of cediranib maleate and selumetinib sulfate in treating patients with solid malignancies. Cediranib maleate and selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cedira…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Chemotherapy delivered directly to abdomen shows promise in early trial
Disease control OngoingThis study is to test escalating doses of intraperitoneal (IP) oxaliplatin in conjunction with systemic bevacizumab and capecitabine in patients with Peritoneal Carcinomatosis (PC) from either appendiceal or colorectal adenocarcinoma that have been adequately cytoreduced and have…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 26, 2026 18:01 UTC
-
New drug combo shows promise in early breast cancer trial
Disease control OngoingThis phase I trial studies the side effects and best dose of cyclophosphamide and veliparib when given together in treating patients with breast cancer that has spread from where it started to nearby tissue or lymph nodes or to other places in the body. Drugs used in chemotherapy…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Virtual supermarket training shows promise for stroke recovery
Symptom relief Completed* Background : The general experience with the Virtual Reality application approach suggests that this treatment concept is promising in stroke rehabilitation * Purpose : In shopping activity in a real supermarket and in simulated with the investigators virtual shopping simulatio…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Scientists hunt for genes behind mysterious heart artery tears
Knowledge-focused Recruiting nowThe purpose of the research is to identify mutations (defects in the genetic blueprint) that cause spontaneous coronary artery dissection (SCAD), in other words, spontaneous tears in blood vessels that supply the heart. Some mutations may be inherited (passed on) from a parent w…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New diabetes drug shows promise in Year-Long trial
Disease control CompletedThe purpose of this study is to evaluate the safety and efficacy of TA-7284 as monotherapy or combination therapy with other oral anti-hyperglycaemic agent in Japanese patients with Type 2 diabetes mellitus on 52 weeks oral administration.
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug cocktail targets tough cancers in early trial
Disease control CompletedCetuximab is an EGFR inhibitor that has shown efficacy alone or in combination in colorectal cancer or head and neck cancer in several phase II/III studies. Temsirolimus is a new mTOR inhibitor that has shown interesting results in several Phase I/II studies in advance kidney ca…
Phase: PHASE1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New combo therapy for seniors with aggressive breast cancer shows promise in early trial
Disease control OngoingThis phase II trial studies the side effects and how well lapatinib ditosylate and trastuzumab work in treating older patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer that has spread from where it started to nearby tissue or lymph nodes (locall…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Shock therapy for pain? rTMS shows promise for fibromyalgia
Symptom relief CompletedThe purpose of this study is to determine the analgesic effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) used as an additional procedure to rehabilitation exercises in patient suffering from fibromyalgia. A double blind clinical trial with two randomized para…
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New blood test could spot spread of rare eye cancer
Knowledge-focused CompletedCirculating tumor DNA detection and quantification in patients with metastatic choroidal melanoma.
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC